Clinical Trials Browser

Phase 3 × Adenocarcinoma × Epirubicin × Clear all

NCT00140075 2011-05-26

Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer

Phase 3 Completed

Adenocarcinoma